BMC Cancer · 2012 · 53 citations · 21 references
MedicineMolecular BiologyOncologyGene ExpressionMetastasisMolecular OncologyCancer Cell SignalingEwing SarcomaMalignant NeoplasmsMetastatic Signaling PathwaysSignal Transduction In CancerWnt SignalingBiological PrognosisCancer Metastasis BiomarkersCanonical Wnt PathwayCanonical Wnt SignalingEwing Sarcoma Cell LinesNon-canonical Wnt PathwayNoncanonical Wnt SignalingWnt Antagonists
BACKGROUND: As one of the malignant tumors most often affecting children and young adults, Ewing sarcoma (ES) is characterized by early metastasis contributing to unfavorable prognosis. However, the molecular mechanisms responsible for ES metastasis remain poorly understood. In this study, we aimed to explore whether Wnt5a, a putative pro-metastatic factor, plays a role in ES metastasis. METHODS: Expression of Wnt5a and CXCR4 was determined by real-time PCR or Western blot in 15 ES specimens and 4 ES cell lines, A-673, RD-ES, SK-N-MC and SK-ES-1. Expression of Wnt antagonists, SFRP1, SFRP2 and SFRP5, and some components in noncanonical Wnt pathway (p-JNK, p-cJUN and p-PKC) was also analyzed in this study. Methylation status of SFRP1, SFRP2 and SFRP5 was detected by Methylation-specific PCR (MSP). Wnt5a shRNA and pcDNA3.1 SFRP5 vector were used to abrogate Wnt5a expression and overexpress SFRP5 in ES cells, respectively. RESULTS: Wnt5a expression was positively correlated with CXCR4 expression in ES specimens. Levels of both Wnt5a mRNA and CXCR4 mRNA were significantly higher in specimens from ES patients with metastasis at diagnosis compared with specimens from those without metastasis. Recombinant Wnt5a enhanced CXCR4 expression in ES cells, which was accompanied by increased ES cell migration, whereas Wnt5a shRNA has opposite effects. SFRP5 was methylated and silenced in ES cells, and both recombinant SFRP5 and pcDNA3.1 SFRP5 vector suppressed CXCR4 expression as well as ES cell migration. Wnt5a shRNA and recombinant SFRP5 inhibited phosphorylation of JNK and cJUN, and JNK inhibitor also reduced CXCR4 expression and cell migration in ES cells. CONCLUSIONS: Wnt5a increases ES cell migration via upregulating CXCR4 expression in the absence of Wnt antagonist SFRP5, suggesting that Wnt5a overexpression and SFRP5 deficiency may jointly promote ES metastasis.
21
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma
Ashani T. Weeraratna, Yuan Jiang, Galen Hostetter et al. · Cancer Cell · 2002 · 959 citations · Full text
Medicine, Cell Biology, Oncology +14
Sfrp5 Is an Anti-Inflammatory Adipokine That Modulates Metabolic Dysfunction in Obesity
Noriyuki Ouchi, Akiko Higuchi, Koji Ohashi et al. · Science · 2010 · 493 citations · Full text
Samudra K. Dissanayake, Michael S. Wade, Carrie E. Johnson et al. · Journal of Biological Chemistry · 2007 · 368 citations · Full text
Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue
Huiling Liang, Qin Chen, Andrew H. Coles et al. · Cancer Cell · 2003 · 323 citations · Full text
Wnt-5a has tumor suppressor activity in thyroid carcinoma
N Kremenevskaja, R von Wasielewski, A S Rao et al. · Oncogene · 2005 · 263 citations
Medicine, Cancer Biology, Oncology +12